Igene Biotechnology, Inc.
OTC: IGNE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Basic Materials
- Industry
- Agricultural Inputs
- CEO
- Joseph L. Downs
- Employees
- 18
- Headquarters
- Columbia, United States
- IPO year
- 1995
- Market cap
- $15.7K
- Website
- https://www.igene.com
Loading IGNE…
Loading profile data…Frequently asked questions about IGNE
What does Igene Biotechnology, Inc. (IGNE) do?
Igene Biotechnology, Inc. is dedicated to the discovery, development, production, and commercialization of specialized ingredients for both human and animal nutrition. A key offering from the company is natural astaxanthin, a valuable nutrient utilized as a coloring agent for farmed salmon and trout. Additionally, it supplies a variety of ingred...
Where does IGNE trade?
Igene Biotechnology, Inc. (IGNE) trades on the Other OTC.
What sector is IGNE in?
Igene Biotechnology, Inc. (IGNE) operates in the Basic Materials sector, specifically in the Agricultural Inputs industry.
Who is the CEO of Igene Biotechnology, Inc.?
Joseph L. Downs is the chief executive officer of Igene Biotechnology, Inc. (IGNE).
Where is Igene Biotechnology, Inc. headquartered?
Igene Biotechnology, Inc. is headquartered in United States.
Does IGNE pay a dividend?
Igene Biotechnology, Inc. (IGNE) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IGNE go public?
Igene Biotechnology, Inc. (IGNE) completed its initial public offering in 1995.